Abiopharma

News list

Thye Dirk 🟡 adjusted position in 0 shares of Quince Therapeutics, Inc. (QNCX) Transaction Date: Dec 10, 2025 | Filing ID: 001407

Full text

News bot Dec. 12, 2025, 10:12 p.m.
🔍 Thye Dirk (Executive)

Company: Quince Therapeutics, Inc. (QNCX)

Report Date: 2025-12-10
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 739,885
- Total shares sold: 739,885
Detailed Transactions and Holdings:
- Sold 739,885 shares of Common Shares (Direct)
  Date: 2025-12-10 | Code: G | equity_swap_involved: false | shares_owned_after: 255,000.00 | transaction_form_type: 4
- Acquired 739,885 shares of Common Shares (Direct)
  Date: 2025-12-10 | Code: G | equity_swap_involved: false | shares_owned_after: 739,885.00 | transaction_form_type: 4